{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Andrew", "organization": "", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson says he is 'on road to recovery' following hospitalization, but is uncertain when he will return to work.", "multimedia": [{"type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "450"}, "width": 600, "subtype": "xlarge", "height": 450}, {"type": "image", "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Timing of Return to Work Is Unclear for Valeant Chief", "main": "Valeant Chief Says Timing of His Return to Work Is Unclear"}, "print_page": "2", "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "2", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Ingram, Robert A", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Schiller, Howard B", "is_major": "N", "rank": "5", "name": "persons"}], "snippet": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "source": "The New York Times", "lead_paragraph": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "word_count": "350", "pub_date": "2016-01-26T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/01/26/business/valeant-chief-michael-pearson.html", "_id": "56a6283e38f0d81529067dfc"}